{"entity":{"type":"insider","cik":"0001559569","url":"/insider/0001559569","json_url":"/insider/0001559569.json","name":"Pruzanski Mark","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":89,"n_filings":38,"first":"2013-06-21","last":"2020-01-03","span_basis":"filed_date"},"name_variants":[{"name":"Pruzanski Mark","source":"filing","n_filings":38,"first_seen":"2013-06-21","last_seen":"2020-01-03"}],"transactions":[{"id":3328164,"accession":"0001104659-20-001086","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-20-001086","line_url":"/filing/0001104659-20-001086#line-3","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":125.0,"price_display":"125.00","price_state":"stated","total_value":12500.0,"total_display":"12,500.00","total_whole":"12,500","shares_owned_after":469126.0,"shares_owned_after_display":"469,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-31","filed_date":"2020-01-03","scope":"insider"},{"id":7913061,"accession":"0001104659-19-076863","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-076863","line_url":"/filing/0001104659-19-076863#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":125.0,"price_display":"125.00","price_state":"stated","total_value":52125.0,"total_display":"52,125.00","total_whole":"52,125","shares_owned_after":469126.0,"shares_owned_after_display":"469,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-26","filed_date":"2019-12-30","scope":"insider"},{"id":8582529,"accession":"0001104659-19-068397","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-19-068397","line_url":"/filing/0001104659-19-068397#line-6","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35437.0,"shares_display":"35,437","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":3543700.0,"total_display":"3,543,700.00","total_whole":"3,543,700","shares_owned_after":469126.0,"shares_owned_after_display":"469,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-26","filed_date":"2019-11-27","scope":"insider"},{"id":8582511,"accession":"0001104659-19-068397","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-068397","line_url":"/filing/0001104659-19-068397#line-3","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14563.0,"shares_display":"14,563","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":1456300.0,"total_display":"1,456,300.00","total_whole":"1,456,300","shares_owned_after":469126.0,"shares_owned_after_display":"469,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-25","filed_date":"2019-11-27","scope":"insider"},{"id":6284248,"accession":"0001144204-18-060579","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001144204-18-060579","line_url":"/filing/0001144204-18-060579","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27606.0,"shares_display":"27,606","price_per_share":101.54055804535245,"price_display":"101.54","price_state":"stated","total_value":2803128.6454,"total_display":"2,803,128.65","total_whole":"2,803,129","shares_owned_after":584581.0,"shares_owned_after_display":"584,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-16","filed_date":"2018-11-16","scope":"insider","n_lines":4},{"id":6284238,"accession":"0001144204-18-060579","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-18-060579","line_url":"/filing/0001144204-18-060579","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22394.0,"shares_display":"22,394","price_per_share":100.4994423327677,"price_display":"100.50","price_state":"stated","total_value":2250584.5116,"total_display":"2,250,584.51","total_whole":"2,250,585","shares_owned_after":570326.0,"shares_owned_after_display":"570,326","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-15","filed_date":"2018-11-16","scope":"insider","n_lines":2},{"id":6284021,"accession":"0001144204-18-019836","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-18-019836","line_url":"/filing/0001144204-18-019836#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7812.0,"shares_display":"7,812","price_per_share":64.0,"price_display":"64.00","price_state":"stated","total_value":499968.0,"total_display":"499,968.00","total_whole":"499,968","shares_owned_after":576564.0,"shares_owned_after_display":"576,564","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-09","filed_date":"2018-04-09","scope":"insider"},{"id":4287372,"accession":"0001144204-17-051413","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-051413","line_url":"/filing/0001144204-17-051413#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1532.0,"shares_display":"1,532","price_per_share":58.87,"price_display":"58.87","price_state":"stated","total_value":90188.84,"total_display":"90,188.84","total_whole":"90,189","shares_owned_after":568752.0,"shares_owned_after_display":"568,752","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-04","scope":"insider"},{"id":5142331,"accession":"0001144204-17-035811","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-035811","line_url":"/filing/0001144204-17-035811#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1434.0,"shares_display":"1,434","price_per_share":121.78,"price_display":"121.78","price_state":"stated","total_value":174632.52,"total_display":"174,632.52","total_whole":"174,633","shares_owned_after":570284.0,"shares_owned_after_display":"570,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-03","filed_date":"2017-07-05","scope":"insider"},{"id":4949472,"accession":"0001144204-17-034719","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-17-034719","line_url":"/filing/0001144204-17-034719","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":130.7965878125,"price_display":"130.80","price_state":"stated","total_value":5231863.5125,"total_display":"5,231,863.51","total_whole":"5,231,864","shares_owned_after":585139.0,"shares_owned_after_display":"585,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-26","filed_date":"2017-06-28","scope":"insider","n_lines":5},{"id":4127078,"accession":"0001144204-17-019294","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-019294","line_url":"/filing/0001144204-17-019294#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1.187,"shares_display":"1.19","price_per_share":114.9973,"price_display":"115.00","price_state":"stated","total_value":136.5017951,"total_display":"136.50","total_whole":"137","shares_owned_after":571718.0,"shares_owned_after_display":"571,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-03","filed_date":"2017-04-05","scope":"insider"},{"id":4789050,"accession":"0001144204-17-000939","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-000939","line_url":"/filing/0001144204-17-000939#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2802.0,"shares_display":"2,802","price_per_share":103.9191,"price_display":"103.92","price_state":"stated","total_value":291181.3182,"total_display":"291,181.32","total_whole":"291,181","shares_owned_after":552705.0,"shares_owned_after_display":"552,705","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-03","filed_date":"2017-01-05","scope":"insider"},{"id":3226388,"accession":"0001144204-16-127099","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-127099","line_url":"/filing/0001144204-16-127099#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":705.0,"shares_display":"705","price_per_share":163.1997,"price_display":"163.20","price_state":"stated","total_value":115055.7885,"total_display":"115,055.79","total_whole":"115,056","shares_owned_after":552020.0,"shares_owned_after_display":"552,020","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-03","filed_date":"2016-10-05","scope":"insider"},{"id":3048426,"accession":"0001144204-16-124959","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-16-124959","line_url":"/filing/0001144204-16-124959#line-3","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":165.0,"price_display":"165.00","price_state":"stated","total_value":5775000.0,"total_display":"5,775,000.00","total_whole":"5,775,000","shares_owned_after":552725.0,"shares_owned_after_display":"552,725","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-20","filed_date":"2016-09-22","scope":"insider"},{"id":2040687,"accession":"0001144204-16-112099","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-112099","line_url":"/filing/0001144204-16-112099#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":714.0,"shares_display":"714","price_per_share":145.1092,"price_display":"145.11","price_state":"stated","total_value":103607.9688,"total_display":"103,607.97","total_whole":"103,608","shares_owned_after":547566.0,"shares_owned_after_display":"547,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-05","filed_date":"2016-07-07","scope":"insider"},{"id":2172751,"accession":"0001144204-16-093112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-093112","line_url":"/filing/0001144204-16-093112#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":708.0,"shares_display":"708","price_per_share":130.76,"price_display":"130.76","price_state":"stated","total_value":92578.08,"total_display":"92,578.08","total_whole":"92,578","shares_owned_after":548248.0,"shares_owned_after_display":"548,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-04","filed_date":"2016-04-06","scope":"insider"},{"id":2440926,"accession":"0001144204-16-074237","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-16-074237","line_url":"/filing/0001144204-16-074237","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2126.0,"shares_display":"2,126","price_per_share":145.9037,"price_display":"145.90","price_state":"stated","total_value":310191.2662,"total_display":"310,191.27","total_whole":"310,191","shares_owned_after":529681.0,"shares_owned_after_display":"529,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-04","filed_date":"2016-01-05","scope":"insider","n_lines":2},{"id":8403256,"accession":"0001144204-15-058163","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-15-058163","line_url":"/filing/0001144204-15-058163#line-3","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":167.0,"shares_display":"167","price_per_share":159.0393,"price_display":"159.04","price_state":"stated","total_value":26559.5631,"total_display":"26,559.56","total_whole":"26,560","shares_owned_after":526814.0,"shares_owned_after_display":"526,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-02","filed_date":"2015-10-05","scope":"insider"},{"id":8714037,"accession":"0001144204-15-042554","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-15-042554","line_url":"/filing/0001144204-15-042554#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":250.0,"price_display":"250.00","price_state":"stated","total_value":3125000.0,"total_display":"3,125,000.00","total_whole":"3,125,000","shares_owned_after":507014.0,"shares_owned_after_display":"507,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-10","filed_date":"2015-07-14","scope":"insider"},{"id":8608951,"accession":"0001144204-15-041465","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-15-041465","line_url":"/filing/0001144204-15-041465","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":158.0,"shares_display":"158","price_per_share":236.25627151898735,"price_display":"236.26","price_state":"stated","total_value":37328.4909,"total_display":"37,328.49","total_whole":"37,328","shares_owned_after":507023.0,"shares_owned_after_display":"507,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-02","filed_date":"2015-07-07","scope":"insider","n_lines":3},{"id":8178400,"accession":"0001144204-15-032148","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-15-032148","line_url":"/filing/0001144204-15-032148#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":300.0,"price_display":"300.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","total_whole":"1,500,000","shares_owned_after":495743.0,"shares_owned_after_display":"495,743","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-14","filed_date":"2015-05-18","scope":"insider"},{"id":8206502,"accession":"0001144204-15-027775","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001144204-15-027775","line_url":"/filing/0001144204-15-027775","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":253.559574536,"price_display":"253.56","price_state":"stated","total_value":3169494.6817,"total_display":"3,169,494.68","total_whole":"3,169,495","shares_owned_after":498855.0,"shares_owned_after_display":"498,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-01","filed_date":"2015-05-05","scope":"insider","n_lines":8},{"id":8822011,"accession":"0001144204-15-021234","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-15-021234","line_url":"/filing/0001144204-15-021234#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":157.0,"shares_display":"157","price_per_share":277.7006,"price_display":"277.70","price_state":"stated","total_value":43598.9942,"total_display":"43,598.99","total_whole":"43,599","shares_owned_after":495743.0,"shares_owned_after_display":"495,743","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-02","filed_date":"2015-04-03","scope":"insider"},{"id":8755709,"accession":"0001144204-15-001257","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-001257","line_url":"/filing/0001144204-15-001257#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":461.0,"shares_display":"461","price_per_share":176.4857,"price_display":"176.49","price_state":"stated","total_value":81359.9077,"total_display":"81,359.91","total_whole":"81,360","shares_owned_after":491032.0,"shares_owned_after_display":"491,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-05","filed_date":"2015-01-07","scope":"insider"},{"id":7002717,"accession":"0001144204-14-065432","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001144204-14-065432","line_url":"/filing/0001144204-14-065432#line-13","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3166.0,"shares_display":"3,166","price_per_share":260.676,"price_display":"260.68","price_state":"stated","total_value":825300.216,"total_display":"825,300.22","total_whole":"825,300","shares_owned_after":483359.0,"shares_owned_after_display":"483,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-05","scope":"insider"},{"id":7002715,"accession":"0001144204-14-065432","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001144204-14-065432","line_url":"/filing/0001144204-14-065432#line-12","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2950.0,"shares_display":"2,950","price_per_share":261.7064,"price_display":"261.71","price_state":"stated","total_value":772033.88,"total_display":"772,033.88","total_whole":"772,034","shares_owned_after":480409.0,"shares_owned_after_display":"480,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-05","scope":"insider"},{"id":7002714,"accession":"0001144204-14-065432","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001144204-14-065432","line_url":"/filing/0001144204-14-065432#line-11","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":259.4727,"price_display":"259.47","price_state":"stated","total_value":285419.97,"total_display":"285,419.97","total_whole":"285,420","shares_owned_after":486525.0,"shares_owned_after_display":"486,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-05","scope":"insider"},{"id":7002712,"accession":"0001144204-14-065432","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001144204-14-065432","line_url":"/filing/0001144204-14-065432#line-10","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":262.462,"price_display":"262.46","price_state":"stated","total_value":131231.0,"total_display":"131,231.00","total_whole":"131,231","shares_owned_after":479909.0,"shares_owned_after_display":"479,909","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-05","scope":"insider"},{"id":7002711,"accession":"0001144204-14-065432","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001144204-14-065432","line_url":"/filing/0001144204-14-065432#line-9","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":254.2915,"price_display":"254.29","price_state":"stated","total_value":127145.75,"total_display":"127,145.75","total_whole":"127,146","shares_owned_after":488525.0,"shares_owned_after_display":"488,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-05","scope":"insider"},{"id":7002709,"accession":"0001144204-14-065432","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001144204-14-065432","line_url":"/filing/0001144204-14-065432#line-8","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":257.96,"price_display":"257.96","price_state":"stated","total_value":103184.0,"total_display":"103,184.00","total_whole":"103,184","shares_owned_after":487625.0,"shares_owned_after_display":"487,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-05","scope":"insider"},{"id":7002708,"accession":"0001144204-14-065432","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001144204-14-065432","line_url":"/filing/0001144204-14-065432#line-7","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":384.0,"shares_display":"384","price_per_share":250.8021,"price_display":"250.80","price_state":"stated","total_value":96308.0064,"total_display":"96,308.01","total_whole":"96,308","shares_owned_after":489325.0,"shares_owned_after_display":"489,325","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-05","scope":"insider"},{"id":7002706,"accession":"0001144204-14-065432","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-14-065432","line_url":"/filing/0001144204-14-065432#line-6","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559569","owner_name":"Pruzanski Mark","owner_display_name":"Pruzanski Mark","owner_url":"/insider/0001559569","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":255.2967,"price_display":"255.30","price_state":"stated","total_value":76589.01,"total_display":"76,589.01","total_whole":"76,589","shares_owned_after":488225.0,"shares_owned_after_display":"488,225","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-05","scope":"insider"}],"collapsed":true,"next_cursor":"2014-11-03|7002706","ledger_fault":false,"count":{"value":89,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":88,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":89},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001270073","name":"INTERCEPT PHARMACEUTICALS, INC.","url":"/issuer/0001270073","role":"Director, Officer (President & CEO)","n_filings":38,"first_seen":"2013-06-21","last_seen":"2020-01-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001559569","retrieved_at":"2026-08-22T22:56:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}